Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seprox Biotech is a Spanish biotechnology company specializing in the sustainable production of high-purity bioactive compounds through advanced biocatalysis. The company is best known for its proprietary enzymatic process to synthesize hydroxytyrosol, a potent natural antioxidant found in olives, and its derivatives. Their products serve the nutraceutical, cosmetic, and pharmaceutical industries, focusing on applications in cardiovascular health, skin protection, and anti-aging. As a spin-off from the Spanish National Research Council (CSIC), Seprox leverages deep expertise in enzyme engineering to provide eco-friendly alternatives to traditional chemical synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seprox Biotech.